Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.405
-0.135 (-8.77%)
May 6, 2025, 11:52 AM EDT - Market open
Editas Medicine Revenue
In the year 2024, Editas Medicine had annual revenue of $32.31M, down -58.64%. Editas Medicine had revenue of $30.60M in the quarter ending December 31, 2024, a decrease of -49.03%.
Revenue (ttm)
$32.31M
Revenue Growth
-58.64%
P/S Ratio
3.92
Revenue / Employee
$131,358
Employees
246
Market Cap
117.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.31M | -45.81M | -58.64% |
| Dec 31, 2023 | 78.12M | 58.41M | 296.32% |
| Dec 31, 2022 | 19.71M | -5.83M | -22.83% |
| Dec 31, 2021 | 25.54M | -65.19M | -71.85% |
| Dec 31, 2020 | 90.73M | 70.20M | 341.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Thermo Fisher Scientific | 42.90B |
EDIT News
- 20 hours ago - Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May - GlobeNewsWire
- 7 days ago - Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
- 6 weeks ago - Editas Medicine Announces Chief Financial Officer Transition - GlobeNewsWire
- 7 weeks ago - Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates - GlobeNewsWire
- 2 months ago - Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript - Seeking Alpha
- 2 months ago - Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - GlobeNewsWire